// App-Quantinova.ai

TP123 : Open-label Phase I Clinical Study to Assess the Safety and Efficacy of Cilostazol in Patients Undergoing Carotid Artery Angioplasty and Stent Placement

Researchers

Presenter

  • Haralabos Zacharatos

Principal Investigators

  • Mikayel Grigoryan

  • M Fareed K Suri

  • Adnan I Qureshi

  • Saqib A Chaudhry

  • Wondwossen G Tekle

  • Amir Khan

  • Farhan Siddiq

  • Gustavo J Rodriguez

  • Ramachandra Tummala

  • Robert A Taylor

  • Bharathi Jagadeesan

Medical Centers

  • Zeenat Qureshi Stroke Inst., Minneapolis, MN

  • Univ of Texas Health Sciences Ctr San Antonio, Austin, TX

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Intracerebral hemorrhage

  • Venous thrombosis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Clopidogrel bisulfate

  • cilostazol

  • Aspirin

  • Albyl-E

Outcome

  • N/A

Study Design

  • open label

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved